NCT00529308View on ClinicalTrials.gov

Transcranial Magnetic Stimulation (TMS) for Individuals With Tourette's Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Tourette Syndrome
Interventions
DEVICE

Transcranial Magnetic Stimulation (active)

Magstim Rapid2 stimulator with Air Film Coil at 110% motor threshold at 1Hz for 30 minutes.

DEVICE

Transcranial Magnetic Stimulation (sham)

Magstim Rapid2 stimulator with Sham Air Film Coil at 110% motor threshold at 1Hz for 30 minutes.

Trial Locations (2)

10032

New York State Psychiatric Institute, New York

06520

Yale University School of Medicine, New Haven

All Listed Sponsors
collaborator

Tourette Association of America

OTHER

lead

Yale University

OTHER

NCT00529308 - Transcranial Magnetic Stimulation (TMS) for Individuals With Tourette's Syndrome | Biotech Hunter | Biotech Hunter